Masahiro Takeda Selected Research

ASP6432

6/2019	Modulation of urinary frequency via type 1 lysophosphatidic acid receptors: Effect of the novel antagonist ASP6432 in conscious rats.
3/2019	ASP6432, a type 1 lysophosphatidic acid receptor antagonist, reduces urethral function during urine voiding and improves voiding dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masahiro Takeda Research Topics

Disease

8	Biliary Atresia 01/2024 - 01/2019
3	Nocturia 10/2020 - 01/2019
2	Shock 12/2023 - 12/2021
2	Hemorrhage 12/2021 - 01/2020
2	Urologic Diseases (Urinary Tract Disease) 06/2019 - 03/2019
2	Pain (Aches) 01/2018 - 01/2016
2	Hirschsprung Disease (Hirschsprung's Disease) 12/2017 - 08/2017
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2024
1	Cholestasis 01/2024
1	Jaundice (Icterus) 11/2023
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 07/2022
1	Fever (Fevers) 12/2021
1	Diarrhea 12/2021
1	Sarcopenia 08/2021
1	Thrombosis (Thrombus) 08/2021
1	Congenital Hepatic Fibrosis 06/2020
1	Liver Diseases (Liver Disease) 05/2020
1	Hematoma 01/2020
1	Glycogen Storage Disease (Glycogenosis) 01/2020
1	Glucose Intolerance 01/2020
1	Peliosis Hepatis 01/2020
1	Congenital Structural Myopathies (Centronuclear Myopathy) 01/2020
1	End Stage Liver Disease 12/2019
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 06/2019
1	Infertility (Sterility) 01/2019
1	Situs Inversus 01/2019
1	Hepatoblastoma 12/2018
1	Residual Neoplasm 12/2018
1	Neoplasms (Cancer) 12/2018
1	Fabry Disease (Fabry's Disease) 05/2018
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 05/2018
1	Renal Insufficiency (Renal Failure) 05/2018
1	Lower Urinary Tract Symptoms 01/2018
1	Hyperplasia 01/2018
1	Osteoporosis 11/2017
1	Reperfusion Injury 03/2017
1	Ischemia 03/2017
1	Appendicitis 12/2016
1	Pancreatic Diseases (Pancreatic Disease) 09/2002

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2019
2	AcidsIBA 01/2024 - 10/2019
2	ASP6432IBA 06/2019 - 03/2019
2	tyrosine-4-azophenyltrimethylammonium chloride (TAPT)IBA 12/2017 - 08/2017
1	GlucuronidesIBA 01/2024
1	Glycocholic AcidIBA 01/2024
1	Cholic AcidsIBA 01/2024
1	Bile Acids and Salts (Bile Acids)IBA 01/2024
1	BilirubinIBA 01/2024
1	Prednisolone (Predate)FDA LinkGeneric 11/2023
1	Atropine FDA LinkGeneric 07/2022
1	Midodrine (Midon)FDA LinkGeneric 07/2022
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 07/2022
1	Adrenergic Receptors (Adrenergic Receptor)IBA 07/2022
1	Explosive Agents (Explosives)IBA 12/2021
1	hydracrylic acidIBA 10/2020
1	Serotonin (5 Hydroxytryptamine)IBA 10/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 05/2020
1	Reticulin (Reticular Fiber)IBA 01/2020
1	Glucose-6-PhosphateIBA 01/2020
1	myotubularinIBA 01/2020
1	9-hydroxyoctadecadienoic acidIBA 10/2019
1	palmidrolIBA 10/2019
1	13-hydroxy-9,11-octadecadienoic acidIBA 10/2019
1	anandamide (arachidonylethanolamide)IBA 10/2019
1	4- hydroxy- 5,7,10,13,16,19- docosahexaenoic acidIBA 10/2019
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2019
1	Eicosapentaenoic AcidIBA 10/2019
1	Arachidonic Acid (Vitamin F)IBA 10/2019
1	EndocannabinoidsIBA 10/2019
1	thiazolidine-4-carboxylic acidIBA 01/2019
1	A-factor (Streptomyces)IBA 01/2019
1	lauric acid (dodecanoic acid)IBA 01/2019
1	Glycerol (Glycerine)FDA LinkGeneric 01/2019
1	imidazolelactic acidIBA 01/2019
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 12/2018
1	alpha-Galactosidase (Beano)IBA 05/2018
1	Bradykinin B2 ReceptorIBA 01/2018
1	Bradykinin B2 Receptor AntagonistsIBA 01/2018
1	BradykininIBA 01/2018
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2018
1	Analgesics (Analgesic Drugs)IBA 01/2018
1	FR 173657IBA 01/2018
1	SirtuinsIBA 11/2017
1	Endothelin Receptors (Endothelin Receptor)IBA 08/2017
1	Semaphorin-3AIBA 03/2017
1	Nerve Growth Factor (NGF)IBA 01/2016
1	Capsaicin (Zostrix)FDA Link 01/2016
1	Secretin FDA Link 09/2002

Therapy/Procedure

10	Liver Transplantation 12/2021 - 01/2019
3	Drug Therapy (Chemotherapy) 06/2019 - 01/2018
2	Laparotomy 12/2021 - 08/2021
2	Therapeutics 05/2020 - 06/2019
1	Lasers (Laser) 12/2023
1	Hepatectomy 01/2020
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 10/2019
1	Operative Surgical Procedures 01/2019
1	Transplantation 12/2018
1	Enzyme Replacement Therapy 05/2018
1	Peritoneal Dialysis 05/2018
1	Conservative Treatment 12/2016